Top Health-care stocks:
Health-care shares were mixed in pre-market trade on Tuesday.
In health-care stocks news, Cellectar Biosciences ( CLRB ), an oncology-focused biotechnology company, has been granted a U.S. patent covering the method of use for its lead compound, CLR 131, as well as CLR 125, to treat cancer.
Shares in the company were 15.2% higher at $1.59 pre-bell. The stock has traded between $1 and $7.40 over the past 52 weeks.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.